B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways
Authors
Keywords
-
Journal
BLOOD
Volume 120, Issue 12, Pages 2529-2536
Publisher
American Society of Hematology
Online
2012-08-15
DOI
10.1182/blood-2012-06-438911
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cutting Edge: CD25+ Regulatory T Cells Prevent Expansion and Induce Apoptosis of B Cells Specific for Tissue Autoantigens
- (2014) I. Ludwig-Portugall et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: The Dependence of Plasma Cells and Independence of Memory B Cells on BAFF and APRIL
- (2014) M. J. Benson et al. JOURNAL OF IMMUNOLOGY
- Bone Marrow B cell Precursor Number after Allogeneic Stem Cell Transplantation and GVHD Development
- (2012) Yuri Fedoriw et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence
- (2012) S. Arai et al. BLOOD
- Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans
- (2011) M. Srinivasan et al. BLOOD
- Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia
- (2010) Z. Kuzmina et al. BLOOD
- Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease
- (2010) S. Sarantopoulos et al. BLOOD
- Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones
- (2010) I. Isnardi et al. BLOOD
- Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study
- (2010) S. J. Kim et al. HAEMATOLOGICA
- Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation
- (2010) Ken-ichi Matsuoka et al. JOURNAL OF CLINICAL INVESTIGATION
- Rituximab Treatment before Reduced-Intensity Conditioning Transplantation Associates with a Decreased Incidence of Extensive Chronic GVHD
- (2009) Suzanne van Dorp et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The role of B cells in the pathogenesis of graft-versus-host disease
- (2009) A. Shimabukuro-Vornhagen et al. BLOOD
- Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease
- (2009) S. Sarantopoulos et al. BLOOD
- BH3-only proteins and their roles in programmed cell death
- (2009) M Giam et al. ONCOGENE
- Elevated Numbers of Immature/Transitional CD21− B Lymphocytes and Deficiency of Memory CD27+ B Cells Identify Patients with Active Chronic Graft-versus-Host Disease
- (2008) Hildegard T. Greinix et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells
- (2008) B. E. Anderson et al. BLOOD
- Rituximab as salvage therapy for refractory chronic GVHD
- (2008) M Mohty et al. BONE MARROW TRANSPLANTATION
- BAFF activates Akt and Erk through BAFF-R in an IKK1-dependent manner in primary mouse B cells
- (2008) K. L. Otipoby et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival
- (2007) R. T. Woodland et al. BLOOD
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started